These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8878218)

  • 1. Comparison study of the immunogenicity and safety of 5- and 10-microgram dosages of a recombinant hepatitis B vaccine in healthy children.
    Goldfarb J; Medendorp SV; Nagamori K; Buscarino C; Krause D
    Pediatr Infect Dis J; 1996 Sep; 15(9):768-71. PubMed ID: 8878218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison study of the immunogenicity and safety of 5- and 10-microgram dosages of a recombinant hepatitis B vaccine in healthy infants.
    Goldfarb J; Medendorp SV; Garcia H; Nagamori K; Rathfon H; Krause D
    Pediatr Infect Dis J; 1996 Sep; 15(9):764-7. PubMed ID: 8878217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.
    Schiff GM; Sherwood JR; Zeldis JB; Krause DS
    J Adolesc Health; 1995 Jan; 16(1):12-7. PubMed ID: 7742331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of two recombinant hepatitis B vaccines in older individuals.
    Treadwell TL; Keeffe EB; Lake J; Read A; Friedman LS; Goldman IS; Howell CD; DeMedina M; Schiff ER; Jensen DM
    Am J Med; 1993 Dec; 95(6):584-8. PubMed ID: 8259774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children.
    Raz R; Dagan R; Gallil A; Brill G; Kassis I; Koren R
    Vaccine; 1996 Feb; 14(3):207-11. PubMed ID: 8920701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of 5 and 10 microgram doses of two recombinant hepatitis B vaccines.
    Bryan JP; Craig PG; Reyes L; Hakre S; Jaramillo R; Harlan H; MacArthy P; Legters LJ
    Vaccine; 1995 Aug; 13(11):978-82. PubMed ID: 8525691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B.
    Martins RM; Bensabath G; Arraes LC; Oliveira Mde L; Miguel JC; Barbosa GG; Camacho LA
    Mem Inst Oswaldo Cruz; 2004 Dec; 99(8):865-71. PubMed ID: 15761604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates.
    Yerushalmi B; Raz R; Blondheim O; Shumov E; Koren R; Dagan R
    Pediatr Infect Dis J; 1997 Jun; 16(6):587-92. PubMed ID: 9194109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers.
    Kang G; Ma F; Chen H; Yang Y; Guo S; Wang Z; Liang X; Li L; Cui F; Zhang L
    Vaccine; 2015 Aug; 33(33):4093-9. PubMed ID: 26144895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
    el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
    Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two hepatitis B vaccines (GeneVac-B and Engerix-B) in healthy infants in India.
    Shivananda ; Somani V; Srikanth BS; Mohan M; Kulkarni PS
    Clin Vaccine Immunol; 2006 Jun; 13(6):661-4. PubMed ID: 16760324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants. Hib-HB Vaccine Study Group.
    West DJ; Hesley TM; Jonas LC; Feeley LK; Bird SR; Burke P; Sadoff JC
    Pediatr Infect Dis J; 1997 Jun; 16(6):593-9. PubMed ID: 9194110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of two commercial recombinant vaccines for hepatitis B in adolescents.
    Leroux-Roels G; Abraham B; Fourneau M; De Clercq N; Safary A
    Vaccine; 2000 Nov; 19(7-8):937-42. PubMed ID: 11115719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a recombinant yeast-derived hepatitis B vaccine (Engerix B) in children.
    Moyes C; Milne A
    N Z Med J; 1988 Apr; 101(843):162-4. PubMed ID: 2965799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in healthy adolescents on two-dose schedule.
    Chen CC; Chang MH; Lee HC; Twu SJ; Safary A
    Acta Paediatr Taiwan; 1999; 40(3):157-60. PubMed ID: 10910606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
    Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
    Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age. The Kaiser-UCLA Vaccine Study Group.
    Greenberg DP; Vadheim CM; Marcy SM; Partridge S; Jing J; Chiu CY; Greene T; Margolis HS; Ward JI
    Vaccine; 1996 Jun; 14(8):811-6. PubMed ID: 8817829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccine booster dose: low-dose recombinant hepatitis B vaccines as a booster dose.
    Bryan JP; MacArthy P; Rudock A; Fogarty JP; Dowd H; Legters LJ; Perine PL
    Am J Infect Control; 1997 Jun; 25(3):215-22. PubMed ID: 9202817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the immunogenicity and safety of two dosing schedules of hepatitis B vaccine in neonates.
    Bassily S; Kotkat A; Gray G; Hyams KC; Brown FM; Imam IZ; Arthur R
    Am J Trop Med Hyg; 1995 Oct; 53(4):419-22. PubMed ID: 7485697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.